Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss is a research paper published in Oncotarget (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: UM1 CA186688
NCI NIH HHS
Grant: T32 CA009599
NCI NIH HHS
Grant: P30 CA016672
NCATS NIH HHS
Grant: UL1 TR003167
National Institutes of Health
Grant: 3UM1CA186688-03S4
Southwest Early Clinical Trials Consortium
National Institutes of Health
Grant: 5T32CA009599-19
Training of Academic Surgical Oncologists
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
FWCI
1.27
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals